NCT03390920View on ClinicalTrials.gov

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2030

Conditions
OsteoarthritisTendinitisSports InjuryDegenerative Disc DiseaseDegenerative ArthritisLigament InjuryNeuropathyPelvic Pain
Interventions
OTHER

Umbilical Allograft

The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.

Trial Locations (1)

91316

Advanced Stem Cell Institute, Encino

All Listed Sponsors
lead

R3 Stem Cell

INDUSTRY

NCT03390920 - Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions | Biotech Hunter | Biotech Hunter